State of the Art for Diagnosis of Bacterial Vaginosis
- PMID: 37199636
- PMCID: PMC10446871
- DOI: 10.1128/jcm.00837-22
State of the Art for Diagnosis of Bacterial Vaginosis
Abstract
Bacterial vaginosis (BV) is the most common cause of vaginal discharge among reproductive-age women. It is associated with multiple adverse health outcomes, including increased risk of acquisition of HIV and other sexually transmitted infections (STIs), in addition to adverse birth outcomes. While it is known that BV is a vaginal dysbiosis characterized by a shift in the vaginal microbiota from protective Lactobacillus species to an increase in facultative and strict anaerobic bacteria, its exact etiology remains unknown. The purpose of this minireview is to provide an updated overview of the range of tests currently used for the diagnosis of BV in both clinical and research settings. This article is divided into two primary sections: traditional BV diagnostics and molecular diagnostics. Molecular diagnostic assays, particularly 16S rRNA gene sequencing, shotgun metagenomic sequencing, and fluorescence in situ hybridization (FISH), are specifically highlighted, in addition to multiplex nucleic acid amplification tests (NAATs), given their increasing use in clinical practice (NAATs) and research studies (16S rRNA gene sequencing, shotgun metagenomic sequencing, and FISH) regarding the vaginal microbiota and BV pathogenesis. We also provide a discussion of the strengths and weaknesses of current BV diagnostic tests and discuss future challenges in this field of research.
Keywords: bacterial vaginosis; diagnosis; molecular diagnostics; vaginal infection.
Conflict of interest statement
The authors declare a conflict of interest. C.A.M. reports receiving grants to her institution from NIAID, Lupin, Abbott Molecular, and Gilead. She also reports honorarium and/or consulting fees from Scynexis, Cepheid, BioNTech, Visby Medical, Elsevier, UpToDate, Abbott Molecular, and Roche. B.V.D.P. reports receiving grants to her institution, honorarium, and/or consulting fees from Abbott Molecular, Becton Dickinson and Company, Binx Health, BioFire, Cepheid, Hologic, Rheonix, Roche, and SpeeDx. The other authors have no conflicts of interest to declare.
Figures


References
-
- Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, Donnell D, Celum C, Kapiga S, Delany S, Bukusi EA. 2012. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 9:e1001251. doi:10.1371/journal.pmed.1001251. - DOI - PMC - PubMed
-
- Brotman RM, Klebanoff MA, Nansel TR, Yu KF, Andrews WW, Zhang J, Schwebke JR. 2010. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis 202:1907–1915. doi:10.1086/657320. - DOI - PMC - PubMed
-
- Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG, II, Rao AV. 1995. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 333:1737–1742. doi:10.1056/NEJM199512283332604. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical